Washing red blood cells and platelets transfused in cardiac surgery reduces postoperative inflammation and number of transfusions: Results of a prospective, randomized, controlled clinical trial

Pediatric Critical Care Medicine

Volumn 13, Issue 3, 2012, Pages 290-299

  Cholette, Jill M ^a   Henrichs, Kelly F ^a   Alfieris, George M ^b   Powers, Karen S ^a   Phipps, Richard ^b   Spinelli, Sherry L ^a   Swartz, Michael ^b   Gensini, Francisco ^b   Daugherty, L Eugene ^a   Nazarian, Emily ^a   Rubenstein, Jeffrey S ^a   Sweeney, Dawn ^b   Eaton, Michael ^b   Lerner, Norma B ^c   Blumberg, Neil ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

C reactive protein; cardiac surgery; cardiopulmonary bypass; congenital heart disease; inflammation; transfusion

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; C REACTIVE PROTEIN; DOPAMINE; HEPARIN; INTERLEUKIN 10; INTERLEUKIN 6; MILRINONE; PROTAMINE; STEROID;

ADOLESCENT; ADULT; BLOOD; BLOOD GROUP ABO SYSTEM; BLOOD SAMPLING; BLOOD STORAGE; BLOOD TRANSFUSION REACTION; CARDIOPULMONARY ARREST; CARDIOPULMONARY BYPASS; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART SURGERY; HUMAN; HYPOTENSION; HYPOTHESIS; HYPOVOLEMIA; INFANT; INTENSIVE CARE UNIT; LABORATORY TEST; LAVAGE; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFLAMMATION; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK REDUCTION; SCHOOL CHILD; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TACHYCARDIA; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD LOSS, SURGICAL; BLOOD SPECIMEN COLLECTION; C-REACTIVE PROTEIN; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; MALE; PLATELET TRANSFUSION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84861130770     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31822f173c     Document Type: Review

References (71)

1. Levy JH, Tanaka KA: Infammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003; 75:S715-S720
2. Edmunds LH: Infammatory response to car-diopulmonary bypass. Ann Thorac Surg 1998; 66:S12-S16
3. Gessler P, Pretre R, Hohl V, et al: CXC-chemokine stimulation of neutrophils correlates with plasma levels of myeloperoxidase and lactoferrin and contributes to clinical outcome after pediatric cardiac surgery. Shock 2004; 22:513-520 (Pubitemid 39576578)
4. Chowdhury D, Ojamaa K, Parnell VA, et al: A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease. J Thorac Cardiovasc Surg 2001; 12:1023-1025
5. de Mendonca-Filho HT, Gomes RV, de Almeida Campos LA, et al: Circulating levels of mac-rophage migration inhibitory factor are associated with mild pulmonary dysfunction after car-diopulmonary bypass. Shock 2004; 22:533-537 (Pubitemid 39582779)
6. Finkel MS, Oddis CV, Jacob TD, et al: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:387-389
7. Gando S, Nishihira J, Kemmotsu O, et al: An increase in macrophage migration inhibitory factor release in patients with cardiopul-monary bypasss surgery. Surg Today 2000; 30:689-694
8. McMahon CK, Klein I, Ojamaa K: Interleukin-6 and thyroid hormone metabolism in pediatric cardiac surgery patients. Thyroid 2003; 301-304 (Pubitemid 36459314)
9. Stayer SA, Diaz LK, East DL, et al: Changes in respiratory mechanics among infants undergoing heart surgery. Anesth Analg J 2004; 38:307-311
10. Hirai S: Systemic infammatory response syndrome after cardiac surgery under cardiopul-monary bypass. Ann Thorac Cardiovasc Surg 2003; 9:365-370
11. Holmes JH IV, Connolly NC, Paull DL, et al: Magnitude of the infammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Infamm Res 2002; 51:579-586 (Pubitemid 36140268)
12. Madhok AB, Ojamaa K, Haridas V, et al: Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol 2006; 27:408-413 (Pubitemid 44222391)
13. Allen ML, Hoschtitzky JA, Peters MJ, et al: Interleukin-10 and its role in clinical immu-noparalysis following pediatric cardiac surgery. Crit Care Med 2006; 34:2658-2665 (Pubitemid 44413068)
14. Varan B, Tokel K, Mercan S, et al: Systemic infammatory response related to cardiopul-monary bypass and its modifcation by methyl prednisolone: High dose versus low dose. Pediatr cardiol 2002; 23:437-441 (Pubitemid 36927867)
15. Hamada Y, Kohtani T, Nakata T, et al: Blood transfusion under cardiopulmonary bypass is a possible inducer for infammation. Kyobu Geka 2001; 54:835-838
16. Bilgin YM, van de Watering LM, Eijsman L, et al: Double-blind, randomized controlled trial on the effect of leukocyte-depleted eryth-rocyte transfusions in cardiac valve surgery. Circulation 2004; 109:2755-2760 (Pubitemid 38744552)
17. van de Watering LM, Hermans J, Houbiers JG, et al: Benefcial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomized clinical trial. Circulation 1998; 97:562-568 (Pubitemid 28090685)
18. Zacharias A, Habib RH: Factors predisposing to median sternotomy complications. Deep vs. superfcial infection. Chest 1996; 110:1173-1178 (Pubitemid 26380468)
19. Leal-Noval SR, Marques-Vacaro JA, Garcia-Curiel A, et al: Nosocomial pneumonia in patients undergoing heart surgery. Crit Care Med 2000; 28:935-940 (Pubitemid 30262058)
20. Ranucci M, Pavesi M, Mazza E, et al: Risk factors for renal dysfunction after coronary surgery: the role of cardiopulmonary bypass technique. Perfusion 1994; 9:319-326 (Pubitemid 24308136)
21. Michalopoulos A, Stavridis G, Geroulanos S: Severe sepsis in cardiac surgical patients. Eur J Surg 1998; 164:217-222 (Pubitemid 28155477)
22. Engoren MC, Habib RH, Zacharias A, et al: Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002; 74:1180-1186 (Pubitemid 35176743)
23. Michalopoulos A, Tzelepis G, Dafni U, et al: Determinants of hospital mortality after coronary artery bypass grafting. Chest 1999; 115:1598-1603 (Pubitemid 29275651)
24. Willems A, Harrington K, Lacroix J, et al: Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: A subgroup analysis. Crit Care Med 2010; 38:649-656
25. Cholette JM, Rubenstein JS, Alferis GM, et al: Children with single ventricle physiology do not beneft from higher hemoglobin levels post cavopulmonary connection: Results of a prospective, randomized controlled trial of a restrictive versus liberal red-cell transfusion strategy. Pediatr Crit Care Med 2011; 1:39-45
26. Kao KJ: Mechanisms and new approaches for the allogenic blood transfusion-induced im-munomodulatory effects. Transfus Med Rev 2000; 14:12-22 (Pubitemid 30055946)
27. Kirkley SA, Cowles J, Pellegrini VD Jr, et al: Cytokine secretion after allogeneic or au-tologous blood transfusion. Lancet 1995; 345:527
28. Kirkley SA, Cowles J, Pellegrini VD Jr, et al: Blood transfusion and total joint replacement surgery: T helper 2 (Th2) cytokine secretion and clinical outcome. Tranfus Med 1998; 8:195-204 (Pubitemid 28436923)
29. Blajchman MA, Bordin JO: Mechanisms of transfusion-associated immunosuppression. Curr Opin Hematol 1994; 1:457-461
30. Jensen LS, Andersen AJ, Christiansen PM, et al: Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79:513-516
31. Brunson ME, Alexander JW: Mechanisms of transfusion-induced immunosuppression. Transfusion 1990; 30:651-658 (Pubitemid 20317440)
32. Blumberg N: Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 2005; 45:33S-39S.
33. Vamvakas EC, Blajchman MA: Deleterious clinical effects of transfusion-associated im-munomodulation: fact or fction? Blood 2001; 97:1180-1195 (Pubitemid 32183738)
34. Bordin JO, Heddle NM, Blajchman MA: Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994; 84:1705-1721
35. Frabetti F, Musiani D, Marini M, et al: White cell apoptosis in packed red cells. Transfusion 1998; 38:1082-1089 (Pubitemid 28549011)
36. Mincheff M: Changes in donor leukocytes during blood storage. Implications on post-transfusion immunomodulation and transfusion-associated GVHD. Vox Sang 1998; 74(Suppl 2):189-200 (Pubitemid 28379783)
37. Nielsen HJ, Reimert CM, Pedersen AN, et al: Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 1996; 36:960-965 (Pubitemid 26394140)
38. Ghio M, Contini P, Mazzei C, et al: In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: Do they play a role in autologous blood transfusion? Transfusion 2001; 41:988-996 (Pubitemid 33642787)
39. Kristiansson M, Soop M, Saraste L, et al: Cytokines in stored red blood cell concentrates: promoters of systemic infamma-tion and simulators of acute transfusion reactions? Acta Anaesthesiol Scand 1996; 40:496-501 (Pubitemid 26151562)
40. Magee CC, Sayegh MH: Peptide-mediated im-munosuppression. Curr Opin Immunol 1997; 9:669-675
41. Silliman CC, Clay KL, Thurman GW, et al: Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994; 124:684-694
42. Silliman CC, Johnson CA, Clay KL, et al: Compounds biologically similar to platelet activating factor are present in stored blood components. Lipids 1993; 28:415-418 (Pubitemid 23143823)
43. Fransen E, Maessen J, Dentener M, et al: Impact of blood transfusions on infam-matory mediator release in patients undergoing cardiac surgery. Chest 1999; 116:1233-1239 (Pubitemid 29535973)
44. Klein HG, Spahn DR, Carson JL: Red blood cell transfusion in clinical practice. Lancet 2007; 370:415-426 (Pubitemid 47176657)
45. Blumberg N, Heal JM, Gettings K F, et al: An association between decreased cardiopul-monary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 2010; 50:2738-44
46. Blumberg N, Heal JM, Rowe JM: A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia. BMC Blood Dis 2004; 4:6
47. Doughty LA, Kaplan SS, Carcillo JA: Infammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med 1996; 24:1137-1143 (Pubitemid 26249363)
48. Finnerty CC, Herndon DN, Chinkes DL, et al: Serum cytokine differences in severely burned children with and without sepsis. Shock 2007; 27:4-9 (Pubitemid 44968003)
49. Taniguchi T, Koido Y, Aiboshi J, et al: The ratio of interleukin-6 to interleukin-10 correlates with severity in patients with chest and abdominal trauma. Am J Emerg Med 1999; 17:548-551 (Pubitemid 29480843)
50. Taniguchi T, Koido Y, Aiboshi J, et al: Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic infammatory response syndrome. Crit Care Med 1999; 27:1262-1264 (Pubitemid 29379361)
51. Loisa P, Rinne T, Laine S, et al: Anti-infammatory cytokine response and the development of multiple organ failure in severe sepsis. Acta Anaesthesiol Scan 2003; 47:319-325 (Pubitemid 36384671)
52. Day NP, Hien TT, Schollaardt T, et al: The prognostic and pathophysiologic role of pro-and anti-infammatory cytokines in severe malaria. JID 1999; 180:1288-1297 (Pubitemid 30070216)
53. Kalmin ND, Brown DJ: Platelet washing with a blood cell processor. Transfusion 1982; 22:125-127 (Pubitemid 12100242)
54. Vesilind GW, Simpson MB, Shifman MA, et al: Evaluation of a centrifugal blood cell processor for washing platelet concentrates. Transfusion 1988; 28:46-51
55. Vo TD, Cowles J, Heal JM, et al: Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions. Transfusion Med 2001; 11:45-47 (Pubitemid 32180321)
56. Proulx F, Fayon M, Farrell CA, et al: Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest 1996; 109:1033-1037 (Pubitemid 26113649)
57. Monagle P, Chan A, Massicotte P, et al: Antithrombotic therapy in children. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 645S-687S. (Pubitemid 39297967)
58. Sullivan JS, Kilpatrick L, Costarino AT Jr, et al. Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr 1992; 120:510-515
59. Schroeder VA, Pearl JM, Schwartz SM, et al: Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass infammatory mediator expression. Circulation 2003; 107:2823-2828 (Pubitemid 36705993)
60. Eggum R, Ueland T, Mollnes TE, et al: Effect of perfusion temperature on the infammato-ry response during pediatric cardiac surgery. Ann Thorac Surg 2008; 85:611-617
61. Gessler P, Pfenninger J, Pfammatter J, et al: Plasma levels of interleukin-8 and expression of interleukin-8 receptors on circulating neutrophils and monocytes after car-diopulmonary bypass in children. J Thorac and Cardiovasc Surg 2003; 126:718-725 (Pubitemid 37157968)
62. Hietbrink F, Koenderman L, Rijkers G, et al: Trauma: The role of the innate immune system. World J Emerg Surg 2006; 1:15
63. Mokart D, Capo C, Blache JL, et al: Early postoperative compensatory anti-infammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br J Surg 2002; 89:1450-1456
64. Seekamp A, Jochum M, Ziegler M, et al: cy-tokines and adhesion moleculres in elective and accidental trauma-related ischemia/rep-erfusion. J Trauma 1998; 44:874-882 (Pubitemid 28233037)
65. Giannoudis PV, Smith RM, Perry SL, et al: Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-in-fammatory response and subsequent development of sepsis. Intensive Care Med 2000; 26:1076-1081
66. von Heymann C, Langenkamp J, Dubisz N, et al: Posttraumatic immune modulation in chronic alcoholics is associated with multiple organ dysfunction syndrome. J Trauma 2002; 52:95-103 (Pubitemid 34094252)
67. Hatherill M, Tibby SM, Turner C, et al: Procalcitonin and cytokine levels: Relationship to organ failure and mortality in pediatric septic shock. Crit Care Med 2000; 28:2591-2594 (Pubitemid 30604475)
68. Harris MC, D'Angio CT, Gallagher PR, et al: Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entero-colitis, or sepsis syndrome: Correlation with clinical parameters of infammation and mortality. J Pediatr 2005; 147:462-468 (Pubitemid 41446539)
69. Bilgin YM, van de Watering LM, Versteegh MI, et al: Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on infammatory mediators and postoperative complications. Crit Care Med 2010; 38720-721
70. Zallen G, Offner PJ, Moore EE, et al: Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg 1999; 178:570-572 (Pubitemid 30058313)
71. Murphy GJ, Reeves BC, Rogers CA, et al: Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116:2544-2552 (Pubitemid 350179219)